Sign In
Buy QLGN
$3.21
+0 (+0%)
At Close: Feb 17, 2026
Qualigen Therapeutics to Present at the H.C. Wainwright Global Investment Conference
09:15am, Friday, 20'th May 2022
CARLSBAD, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with
Qualigen Therapeutics, Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results
10:00am, Friday, 13'th May 2022 GlobeNewswire Inc.
CARLSBAD, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers wi
Qualigen Therapeutics’ Partner NanoSynex to Present Technology at BioMed Israel
01:17pm, Tuesday, 10'th May 2022 GlobeNewswire Inc.
Innovative Technology Aims to Accelerate Antimicrobial Susceptibility Test Result Times by Six-Fold
Qualigen Therapeutics' Partner NanoSynex to Present Technology at BioMed Israel
09:17am, Tuesday, 10'th May 2022
Innovative Technology Aims to Accelerate Antimicrobial Susceptibility Test Result Times by Six-Fold
Qualigen Therapeutics to Acquire Majority Stake in Diagnostics Technology Company NanoSynex
01:17pm, Tuesday, 03'rd May 2022 GlobeNewswire Inc.
Companies to Collaborate in the Development of Innovative Diagnostics Platform to Combat “Superbugs,” a Rising Global Health Crisis
Qualigen Therapeutics Appoints Shishir Sinha to Lead Diagnostics Division Following Promotion to Senior Vice President
01:15pm, Friday, 29'th Apr 2022 GlobeNewswire Inc.
CARLSBAD, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers
Top Biotech Penny Stocks to Buy Under $1? 3 Exploding Today
07:02pm, Tuesday, 12'th Apr 2022 PennyStocks
Check these 3 under $1 biotech penny stocks out for your list
The post Top Biotech Penny Stocks to Buy Under $1? 3 Exploding Today appeared first on Penny Stocks to Buy, Picks, News and Information |
Top Biotech Penny Stocks to Buy Under $1? 3 Exploding Today
03:02pm, Tuesday, 12'th Apr 2022
Check these 3 under $1 biotech penny stocks out for your list The post Top Biotech Penny Stocks to Buy Under $1? 3 Exploding Today appeared first on Penny Stocks to Buy, Picks, News and Information |
Biotech Stocks News: What's Going on With LIXT, PTE, QLGN and ATNM Stocks Today?
02:15pm, Tuesday, 12'th Apr 2022
Biotech stocks are up today amid an influx of positive news. Here's what investors need to know as these small companies skyrocket.
Qualigen Therapeutics Presents Three Posters of QN-302 at American Association of Cancer Research Conference
02:15pm, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
Data Highlights In Vivo Research and the Potential Mechanism of Action in Pancreatic and Prostate Cancers
Qualigen Surges 80% As QN-302 Shows Potential Preclinical Mechanism Of Action Against Prostate, Pancreatic Cancers
11:24am, Tuesday, 12'th Apr 2022
Qualigen Therapeutics Inc (NASDAQ: QLGN) shares are surging after highlighting posters at the American Association of Cancer Research (AACR). QN-302 showed potent anti-proliferative activity in a p
Qualigen Therapeutics Resumes Worldwide Distribution and Commercial Control Over FastPack®
01:15pm, Tuesday, 05'th Apr 2022 GlobeNewswire Inc.
Company Prepared for Growth and Improved Profitability of its Diagnostics Business
Qualigen Therapeutics, Inc. Reports Year-End 2021 Financial Results
12:00pm, Friday, 01'st Apr 2022 GlobeNewswire Inc.
CARLSBAD, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers
Qualigen Therapeutics Engages TD2 as Contract Research Organization for Preclinical Development of QN-302
01:15pm, Wednesday, 30'th Mar 2022 GlobeNewswire Inc.
CARLSBAD, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers
Qualigen Therapeutics Announces Three Published Abstracts at American Association of Cancer Research Conference
01:15pm, Tuesday, 22'nd Mar 2022 GlobeNewswire Inc.
Abstracts Review Positive In vivo Data and the Potential Mechanism of Action for QN-302 in Pancreatic and Prostate Cancers
